1. Rutland-Brown W, Langlois JA, Thomas KE, Xi YL. Incidence of traumatic brain injury in the United States, 2003. J Head Trauma Rehabil 2006; 21:544-548.
2. Andelic N, Sigurdardottir S, Brunborg C, Roe C. Incidence of hospital-treated traumatic brain injury in the Oslo population. Neuroepidemiology 2008; 30(2):120-8.
3. Education MoHaM. Development and Coordination of Statistical Yearbook of mortality in 2000. Tehran: Ministry of Health and Medical Education; 2001.
4. Yin H, Yang EJ, Park SJ, Han SK. Glycine- and GABA-mimetic Actions of shilajit on the substantia gelatinosa neurons of the trigeminal subnucleus cudalis in mice. Korean J Physiol Pharmacol 2011; 15:285-289.
5. Jayakumar AR, Rao KV, Panickar KS, Moriyama M, Reddy PV, Norenberg MD. Trauma-induced cell swelling in cultured astrocytes. J Neuropathol Exp Neurol 2008; 67:417-427.
6. Lu J, Goh SJ, Tng PY, Deng YY, Ling EA, Moochhala S. Systemic inflammatory response following acute traumatic brain injury. Front Biosci 2009; 14:3795-3813.
7. Roberts I, Schierhout G, Alderson P. Absence of evidence for the effectiveness of five interventions routinely used in the intensive care management of severe head injury: a systematic review. J Neurol Neurosurg Psychiatry 1998; 65:729-733.
Shilajit and Traumatic Brain Injury Khaksari et al
Iran J Basic Med Sci, Vol. 16, No. 7, Jul 2013
863
8. Wang KK, Larner SF, Robinson G, Hayes RL. Neuroprotection targets after traumatic brain injury. Curr Opin Neurol 2006; 19:514-519.
9. Shibnath Ghosal SKS, Yatendra Kumar, Radheyshyam Srivastava, Raj K. Goel, Radharaman Dey, Salil K. Bhattacharya. Anti-ulcerogenic activity of fulvic acids and 4′-methoxy-6-carbomethoxybiphenyl isolated from shilajit. Phytotherapy Research 1988;2(4):187-91.
10. Goel RK, Banerjee RS, Acharya SB. Antiulcerogenic and antiinflammatory studies with shilajit. J Ethnopharmacol 1990; 29:95-103.
11. ASh S. [Effect of "Mumie" on Bone Regeneration and Blood Alkaline Phosphatase in Experimental Fractures of the Tubular Bones]. Ortop Travmatol Protez. 1965 May;26:24-7.
12. Kel'ginbaev NS, Sorokina VA, Stefanidu AG, Ismailova VN. [Treatment of long tubular bone fractures with Mumie Assil preparations in experiments and clinical conditions]. Eksp Khir Anesteziol 1973-; 18:31-35.
13. Mohd. Aamir Mirza MNA, Mohd. Faiyazuddin,, Danish Mahmood RBaGM. Shilajit: An Ancient Panacea. Int J Curr Pharmaceut Rev Res 2010; 1:2-11.
14. Assegid Garedewa MF, Erik Schmolza, Ingolf Lamprecht. Thermal analysis of mumiyo, the legendary folkremedy from the Himalaya region. Thermochimica Acta. 2004; 417( 2):301-9.
15. Aiello A, Fattorusso E, Menna M, Vitalone R, Schrِder HC, Müller WE. Mumijo traditional medicine: fossil deposits from antarctica (chemical composition and beneficial bioactivity). Evid Based Complement Alternat Med 2008; 2011:1-8.
16. Ghosal S LJ, Jaiswal AK, Bhattacharya SK. Effects of Shilajit and its active constituents on learning and memory in rats. Phytother Res 1993a; 7:29 -34.
17. Spassov V. Memory effects of the natural product Mumyo on the water maze in rats. Eur Neuropsychopharmacol 1994; 4:396.
18. Bhattacharya SKaS, A. P. Effects of Shilajit on biogenic free radicals. Phytother Res 1995; 9 56-59.
19. Agarwal SP, Khanna R, Karmarkar R, Anwer MK, Khar RK. Shilajit: A Review. Phytother Res 2007; 21:401-405.
20. Effect of Shilajit on rat brain monoamines. Phytother Res 1992; 6:163-164.
21. Thawatchai Phaechamud JC, Wetwitayaklung P, Chutima Limmatvapirat and Thaksin Srichan. Some Biological Activities and Safety of Mineral Pitch(Mumijo). Silpakorn U Sience & Tech J 2008; 2:7-17.
22. Marmarou A, Foda MA, van den Brink W, Campbell J, Kita H, Demetriadou K. A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J Neurosurg 1994; 80:291-300.
23. keshavarzi ZMK, Razmi Z, Soltani Hekmat A, Naderi V, Rostami S. The effects of cyclooxygenase inhibitors on the brain Iiflammatory response following traumatic brain injury in rats. Iran J Basic Med Sci 2012; 15:1102-1105.
24. Khaksari M, Soltani Z, Shahrokhi N, Moshtaghi G, Asadikaram G. The role of estrogen and progesterone, administered alone and in combination, in modulating cytokine concentration following traumatic brain injury. Can J Physiol Pharmacol 2010; 89:31-40.
25. Shahrokhi N, Khaksari M, Soltani Z, Mahmoodi M, Nakhaee N. Effect of sex steroid hormones on brain edema, intracranial pressure, and neurologic outcomes after traumatic brain injury. Can J Physiol Pharmacol 2010; 88:414-421.
26. O'Connor CA, Cernak I, Vink R. Both estrogen and progesterone attenuate edema formation following diffuse traumatic brain injury in rats. Brain Res 2005; 1062:171-174.
27. Pegg CC, He C, Stroink AR, Kattner KA, Wang CX. Technique for collection of cerebrospinal fluid from the cisterna magna in rat. J Neurosci Methods 2010; 187:8-12.
28. Yoshihiro T KK, Takahiko O,Yoshihisa K,Nobuyuki MI, Shigeaki Y,Shinsuke W, . Transcutaneous cisternal puncture for sampling of cerebral fluid in aweak rat. Exp Anim 2005; 54:193-196.
29. King DR, Cohn SM, Proctor KG. Changes in intracranial pressure, coagulation, and neurologic outcome after resuscitation from experimental traumatic brain injury with hetastarch. Surgery 2004 ; 136:355-363.
30. Klatzo I. Pathophysiological aspects of brain edema. Acta Neuropathol 1987; 72:236-239.
31. Fujimoto M, Takagi Y, Aoki T, Hayase M, Marumo T, Gomi M, et al. Tissue inhibitor of metalloproteinases protect blood-brain barrier disruption in focal cerebral ischemia. J Cereb Blood Flow Metab 2008; 28:1674-1685.
32. Candelario-Jalil E, Yang Y, Rosenberg GA. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 2009 6; 158:983-994.
33. Shibnath Ghosal JL, Sushil K. Singh, Gautam Dasgupta, Joydeep Bhaduri, Mita Mukhopadhyay, Salil K. Bhattacharya. Chemistry of Shilajit, an immunomodulatory Ayurvedic rasayan. Pure Appl Chem (IUPAC) 1990; 62:1285 -1288.
34. Shibnath Ghosal JL, Sushil K. Singh, Gautam Dasgupta, Joydeep Bhaduri, Mita Mukhopadhyay, Salil K. Bhattacharya. Mast cell protecting effects of shilajit and its constituents. Phytother Res 1989; 3:249-252.
35. Park E, Bell JD, Baker AJ. Traumatic brain injury: can the consequences be stopped? CMAJ 2008; 178:1163-1170.
36. Faden AI. Microglial activation and traumatic brain injury. Ann Neurol 2011; 70:345-346.
37. Domowicz MS, Henry JG, Wadlington N, Navarro A, Kraig RP, Schwartz NB. Astrocyte precursor response to embryonic brain injury. Brain Res 2011; 1389:35-49.
38. Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol 2011; 70:374-383.
39. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 2004; 16:1-13.
40. Sarkaki AR, Khaksari M, Soltani Z, Shahrokhi N, Mahmoodi M. Time and dose dependent
Khaksari et al Shilajit and Traumatic Brain Injury
Iran J Basic Med Sci, Vol. 16, No. 7, Jul 2013
864
neuroprotective effects of sex steroid hormones on inflammatory cytokines after traumatic brain injury. J Neurotrauma 2011g 18.
41. Rooker S, Jorens PG, Van Reempts J, Borgers M, Verlooy J. Continuous measurement of intracranial pressure in awake rats after experimental closed head injury. J Neurosci Methods 2003; 131:75-81.
42. Rogatsky GG, Kamenir Y, Mayevsky A. Effect of hyperbaric oxygenation on intracranial pressure elevation rate in rats during the early phase of severe traumatic brain injury. Brain Res 2005; 1047:131- 016.
43. Oddo M, Levine JM, Mackenzie L, Frangos S, Feihl F, Kasner SE, et al. Brain hypoxia is associated with short-term outcome after severe traumatic brain injury independently of intracranial hypertension and low cerebral perfusion pressure. Neurosurgery 2011; 69:1037-0145.
44.Milde LN MJ, Michenfelder JD. Cerebral functional, metabolic, and hemodynamic effects of etomidate in dogs. Anesthesiology 1985; 63:371-377.
45. Lee H, Kim JM, Kim HJ, Lee I, Chang N. Folic acid supplementation can reduce the endothelial damage in rat brain microvasculature due to hyperhomocysteinemia. J Nutr 2005; 135:544-548.
46. Harsahay Meena HP, MC Arya, Zakwan Ahmed. Shilajit: A panacea for high-altitude problems. Int J Ayurveda Res 2010; 1:37-40.
47. B D. Materia Medica of Ayurveda. New Delhi: B Jain Publishers; 1991.
48. S. Ghosal JL, A. K. Jaiswal, S. K. Bhattacharya. Effects of shilajit and its active constituents on learning and memory in rats. Phytother Res 1993; 7:29-34.
49. S. K. Bhattacharya SG. Effect of Shilajit on rat brain monoamines. Phytother Res
1992; 6:163-164.
50. Shahlaie K, Boggan JE, Latchaw RE, Ji C, Muizelaar JP. Posttraumatic vasospasm detected by continuous brain tissue oxygen monitoring: treatment with intraarterial verapamil and balloon angioplasty. Neurocrit Care 2009; 10:61-69.
51. Jaeger M, Dengl M, Meixensberger J, Schuhmann MU. Effects of cerebrovascular pressure reactivity-guided optimization of cerebral perfusion pressure on brain tissue oxygenation after traumatic brain injury. Crit Care Med 2010; 38:1343-137.